PIK3CD and ovarian carcinoma: Several studies investigating PI3K signaling in ovarian cancer have demonstrated enhanced signaling of different nodes of the pathway and how dysregulation of the PI3K/AKT/mTOR pathway contributes to cell proliferation, migration, and chemotherapy resistance.